Literature DB >> 22367179

The prostate cancer bone marrow niche: more than just 'fertile soil'.

Elisabeth A Pedersen1, Yusuke Shiozawa, Kenneth J Pienta, Russell S Taichman.   

Abstract

The hematopoietic stem cell (HSC) niche in the bone marrow has been studied extensively over the past few decades, yet the bone marrow microenvironment that supports the growth of metastatic prostate cancer (PCa) has only been recently considered to be a specialized 'niche' as well. New evidence supports the fact that disseminated tumor cells (DTCs) of PCa actually target the HSC niche, displace the occupant HSCs and take up residence in the pre-existing niche space. This review describes some of the evidence and mechanisms by which DTCs act as molecular parasites of the HSC niche. Furthermore, the interactions between DTCs, HSCs and the niche may provide new targets for niche-directed therapy, as well as insight into the perplexing clinical manifestations of metastatic PCa disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22367179      PMCID: PMC3602965          DOI: 10.1038/aja.2011.164

Source DB:  PubMed          Journal:  Asian J Androl        ISSN: 1008-682X            Impact factor:   3.285


  67 in total

Review 1.  Uncertainty in the niches that maintain haematopoietic stem cells.

Authors:  Mark J Kiel; Sean J Morrison
Journal:  Nat Rev Immunol       Date:  2008-03-07       Impact factor: 53.106

2.  Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4.

Authors:  A Peled; I Petit; O Kollet; M Magid; T Ponomaryov; T Byk; A Nagler; H Ben-Hur; A Many; L Shultz; O Lider; R Alon; D Zipori; T Lapidot
Journal:  Science       Date:  1999-02-05       Impact factor: 47.728

3.  Leuco-erythroblastic anaemia in prostatic cancer. Report of two cases with complete haematological remission.

Authors:  S Eriksson; J Killander; B Wadman
Journal:  Scand J Haematol       Date:  1972

4.  Expression and activation of alpha v beta 3 integrins by SDF-1/CXC12 increases the aggressiveness of prostate cancer cells.

Authors:  Yan-Xi Sun; Ming Fang; Jianhua Wang; Carlton R Cooper; Kenneth J Pienta; Russell S Taichman
Journal:  Prostate       Date:  2007-01-01       Impact factor: 4.104

Review 5.  Bone health in men receiving androgen deprivation therapy for prostate cancer.

Authors:  James A Eastham
Journal:  J Urol       Date:  2007-01       Impact factor: 7.450

6.  Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4.

Authors:  Sigrid Hatse; Katrien Princen; Gary Bridger; Erik De Clercq; Dominique Schols
Journal:  FEBS Lett       Date:  2002-09-11       Impact factor: 4.124

7.  Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100.

Authors:  Bruno Nervi; Pablo Ramirez; Michael P Rettig; Geoffrey L Uy; Matthew S Holt; Julie K Ritchey; Julie L Prior; David Piwnica-Worms; Gary Bridger; Timothy J Ley; John F DiPersio
Journal:  Blood       Date:  2008-12-02       Impact factor: 22.113

Review 8.  Microenvironmental regulation of metastasis.

Authors:  Johanna A Joyce; Jeffrey W Pollard
Journal:  Nat Rev Cancer       Date:  2008-03-12       Impact factor: 60.716

9.  Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche.

Authors:  Fumio Arai; Atsushi Hirao; Masako Ohmura; Hidetaka Sato; Sahoko Matsuoka; Keiyo Takubo; Keisuke Ito; Gou Young Koh; Toshio Suda
Journal:  Cell       Date:  2004-07-23       Impact factor: 41.582

10.  Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo.

Authors:  Yan-Xi Sun; Jingcheng Wang; Charles E Shelburne; Dennis E Lopatin; Arul M Chinnaiyan; Mark A Rubin; Kenneth J Pienta; Russell S Taichman
Journal:  J Cell Biochem       Date:  2003-06-01       Impact factor: 4.429

View more
  22 in total

Review 1.  The role of the microenvironment-dormant prostate disseminated tumor cells in the bone marrow.

Authors:  Hung-Ming Lam; Robert L Vessella; Colm Morrissey
Journal:  Drug Discov Today Technol       Date:  2014-03

Review 2.  [Prostate and bladder cancer: detection of disseminated tumor cells in bone marrow].

Authors:  R Nawroth; D Weckermann; M Retz
Journal:  Urologe A       Date:  2014-04       Impact factor: 0.639

Review 3.  Disseminated tumor cells and dormancy in prostate cancer metastasis.

Authors:  Emma E van der Toom; James E Verdone; Kenneth J Pienta
Journal:  Curr Opin Biotechnol       Date:  2016-02-20       Impact factor: 9.740

Review 4.  The Role of the Microenvironment in Prostate Cancer-Associated Bone Disease.

Authors:  Christina J Turner; Claire M Edwards
Journal:  Curr Osteoporos Rep       Date:  2016-10       Impact factor: 5.096

Review 5.  Bone-targeting agents in prostate cancer.

Authors:  Daniel L Suzman; Sosipatros A Boikos; Michael A Carducci
Journal:  Cancer Metastasis Rev       Date:  2014-09       Impact factor: 9.264

Review 6.  Cancer stem cells in breast and prostate: Fact or fiction?

Authors:  Rocío G Sampayo; Mina J Bissell
Journal:  Adv Cancer Res       Date:  2019-06-13       Impact factor: 6.242

Review 7.  Extracellular Vesicle-Mediated Bone Remodeling and Bone Metastasis: Implications in Prostate Cancer.

Authors:  Kalyani C Patil; Carolina Soekmadji
Journal:  Subcell Biochem       Date:  2021

Review 8.  Current and emerging therapies for bone metastatic castration-resistant prostate cancer.

Authors:  Jeremy S Frieling; David Basanta; Conor C Lynch
Journal:  Cancer Control       Date:  2015-01       Impact factor: 3.302

Review 9.  Navigating the bone marrow niche: translational insights and cancer-driven dysfunction.

Authors:  Michaela R Reagan; Clifford J Rosen
Journal:  Nat Rev Rheumatol       Date:  2015-11-26       Impact factor: 20.543

10.  Niche inheritance: a cooperative pathway to enhance cancer cell fitness through ecosystem engineering.

Authors:  Kimberline R Yang; Steven M Mooney; Jelani C Zarif; Donald S Coffey; Russell S Taichman; Kenneth J Pienta
Journal:  J Cell Biochem       Date:  2014-09       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.